| Title | Meetings: Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act |
| ToC Doc | Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act |
| Docket Number | 2022-03926 |
| Type | Notice |
| Subject | Meetings: Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act |
| Publication Date | 2022-02-24 |
| Last Updated Date | 2022-02-23 08:15:09 -0500 |
| Last Public Inspection | 2022-02-23 |
| Filed At | 2022-02-23T08:45:00.000-05:00 |
| 2022-03926_PI.pdf (111448 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 7 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...